NCT00153075View on ClinicalTrials.gov

Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 26, 2005

Primary Completion Date

December 7, 2005

Study Completion Date

December 7, 2005

Conditions
Pulmonary Disease, Chronic ObstructiveAsthma
Interventions
DEVICE

Berodual Respimat

DEVICE

Berodual HFA-MDI

Trial Locations (1)

82131

Inamed Research GmbH & Co. KG, Gauting

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY